MEDIFAST INC (MED)
Official siteCONSUMER CYCLICAL • PERSONAL SERVICES • NYSE
Market Cap: $145.04M
Last updated: Nov 17, 2026 at 11:06 AM ET
MEDIFAST INC (MED) Stock Forecast
Analysts expect MEDIFAST INC (MED) to earn -$0.86 per share in the fiscal year ending Dec 31, 2026, on revenue of $288.50M. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.04.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates fall 4.9%.
- Fiscal year ending Dec 31, 2026
- -$0.86
- EPS consensus, revenue $288.50M
- Fiscal year ending Dec 31, 2027
- -$0.04
- EPS consensus, revenue $274.50M
- Next report
- Feb 15, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.86 | -$0.86 to -$0.86 | 1 | $288.50M | $288.50M to $288.50M | 1 |
| Dec 31, 2027 | -$0.04 | -$0.04 to -$0.04 | 1 | $274.50M | $274.50M to $274.50M | 1 |
Quarterly Estimates
The EPS consensus falls from $0.01 for the quarter ending Dec 31, 2026 to -$0.06 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.01 | $0.01 to $0.01 | 2 | $64.03M | $62.13M to $66.57M | 2 |
| Mar 31, 2027 | -$0.06 | -$0.06 to -$0.06 | 1 | $70.10M | $70.10M to $70.10M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.85.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.86 | -$1.15 | -$1.15 | -$1.15 | -$1.85 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.04 | -$0.28 | -$0.28 | -$0.28 | -$0.60 | N/A |
| Quarter ending Mar 31, 2027 | -$0.06 | -$0.15 | -$0.15 | -$0.15 | -$0.24 | N/A |
Frequently Asked Questions About MED
What is the MED stock forecast?
Consensus analyst estimates put MEDIFAST INC's EPS at -$0.86 for the fiscal year ending Dec 31, 2026, on revenue of $288.50M.
What EPS do analysts expect from MED next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.86, with estimates from -$0.86 to -$0.86 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.04, with estimates from -$0.04 to -$0.04 from 1 analyst.
What revenue do analysts expect from MEDIFAST INC next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $288.50M, with estimates from $288.50M to $288.50M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $274.50M, with estimates from $274.50M to $274.50M.
How many analysts cover MED?
1 analyst estimates EPS for MEDIFAST INC for the fiscal year ending Dec 31, 2026.
MED pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors